Sign in to view content

Optical Coherence Tomographic Measures as Predictors of Functional Outcome For Diabetic Macular Edema Treated With Dexamethasone Implant

Matias Iglicki, MD

Video
Published 2017

Related

Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)
David S. Boyer, MD
Annual Meeting Talks
2020
Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)
Dante Joseph Pieramici, MD
Annual Meeting Talks
2020
Therapies for Diabetic Macular Edema: What’s in the Pipeline?
Peter K. Kaiser, MD FASRS
Updates from the Field
2018

Category: Diabetic Retinopathy

See more